Some people living with HIV develop antibodies capable of neutralizing many different strains of the virus. New research links this to immune responses that occur early in infection. The findings, ...

Saint Michael and the Dragon, 1503-1505. Found in the Collection of Musée du Louvre, Paris. (Photo by Fine Art Images/Heritage Images/Getty Images) This is part of a continuing series describing ...

New research links immune response of some people living with HIV with development of neutralizing antibodies.

Monoclonal antibodies have proven to be a potent tool in our ability to prevent and treat SARS-CoV-2 infections. The current epidemic is driven in part by naturally occurring variants that elude ...

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for approximately 600 million documented cases of coronavirus disease 2019 (COVID-19), with almost 6.5 million deaths.

When children living with HIV are injected with neutralizing antibodies, the treatment can suppress cells that contain the virus and are capable of reactivating, an early-stage trial found. Details of ...

Human herpesviruses comprise the alpha, beta, and gamma subfamilies and are a widely prevalent group of DNA-enveloped viruses capable of establishing lifelong latent infections in humans and causing ...

“Our results show how different factors boost the formation of antibodies that broadly combat different viral strains. This will pave the way for us to systematically push ahead with the development ...